Opinion

Video

Acalabrutinib-Based Treatment Clinical Trial Updates

Focusing on acalabrutinib-based treatment, Yuliya Linhares, MD, discusses results from the ELEVATE TN clinical trial.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.